European Society of Cardiology (ESC) clinical consensus statement on indications for conduction system pacing, with special contribution of the European Heart Rhythm Association of the ESC and endorsed by the Asia Pacific Heart Rhythm Society, the Canadian Heart Rhythm Society, the Heart Rhythm Society, and the Latin American Heart Rhythm Society
Michael Glikson, Haran Burri, Amr Abdin, Óscar Cano, Karol Čurila, Jan De Pooter, Juan Carlos Díaz, Inga Drossart, Weijian Huang, Carsten W. Israel, Marek Jastrzębski, Jacqueline Joza, Jarkko Karvonen, Daniel Keene, Christophe Leclercq, Wilfried Müllens, Margarida Pujol‐López, Archana Rao, Kevin Vernooy, Pugazhendhi Vijayaraman, Francesco Zanon, Yoav Michowitz, Jens Cosedis Nielsen, Lucas V.A. Boersma, Carina Blomström‐Lundqvist, Mads Brix Kronborg, Mina K. Chung, Hung‐Fat Tse, Habib Khan, Francisco Leyva, Ulises Rojel-Martínez, Marcin Ruciński, Niraj Varma
Abstract
Conduction system pacing (CSP) is being increasingly adopted as a more physiological alternative to right ventricular and biventricular pacing. Since the 2021 European Society of Cardiology pacing guidelines, there has been growing evidence that this therapy is safe and effective. Furthermore, left bundle branch area pacing was not covered in these guidelines due to limited evidence at that time. This Clinical Consensus Statement provides advice on indications for CSP, taking into account the significant evolution in this domain.